Corbus Pharmaceuticals(CRBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CRBP Corbus Pharmaceuticals

Trading 01-26 12:07:25 EST

8.82

+0.09

+1.01%

High8.85	Low8.51	Vol38.43K
Open8.64	D1 Closing8.73	Amplitude3.84%
Mkt Cap154.78M	Tradable Cap108.34M	Total Shares17.55M
T/O335.82K	T/O Rate0.31%	Tradable Shares12.29M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CRBP","market":"US","secType":"STK","nameCN":"Corbus Pharmaceuticals","latestPrice":8.818,"timestamp":1769447233077,"preClose":8.73,"halted":0,"volume":38432,"delay":0,"changeRate":0.010080183276059472,"floatShares":12286700,"shares":17553037,"eps":-5.517979,"marketStatus":"Trading","change":0.088,"latestTime":"01-26 12:07:25 EST","open":8.64,"high":8.845,"low":8.51,"amount":335823.005088,"amplitude":0.038373,"askPrice":8.85,"askSize":100,"bidPrice":8.82,"bidSize":6,"shortable":3,"etf":0,"ttmEps":-5.517979,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1769461200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":8.73,"preHourTrading":{"tag":"盘前","latestPrice":8.73,"preClose":8.73,"latestTime":"09:22 EST","volume":31,"amount":269.54999100000003,"timestamp":1769437343425,"change":0,"changeRate":0,"amplitude":0.030928},"postHourTrading":{"tag":"盘后","latestPrice":8.73,"preClose":8.73,"latestTime":"17:28 EST","volume":468,"amount":4074.34,"timestamp":1769207282315,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.737942,"impliedVol":0.5315,"impliedVolPercentile":0.0598},"requestUrl":"/m/hq/s/CRBP/wiki","defaultTab":"wiki","newsList":[{"id":"2605286637","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2605286637","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605286637?lang=en_us&edition=fundamental","pubTime":"2026-01-24 06:21","pubTimestamp":1769206860,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  slid 1.47% to $8.73 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.28% to 23,501.24 and the Dow Jones Industrial Average  falling 0.58% to 49,098.71.The stock's fall snapped a four-day winning streak.Corbus Pharmaceuticals Holdings Inc. closed 57.54% below its 52-week high of $20.56, which the company achieved on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Vanda Pharmaceuticals Inc.  fell 1.11% to $8.01, Fortress Biotech Inc.  fell 2.30% to $3.40, and Viking Therapeutics Inc.  fell 5.49% to $32.22.Trading volume  remained 242,257 below its 50-day average volume of 342,463.Data source: Dow Jones Market Data, FactSet. Data compiled January 23, 2026.This content was created by MarketWatch, which is oper","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2605142346","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2605142346","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605142346?lang=en_us&edition=fundamental","pubTime":"2026-01-21 06:21","pubTimestamp":1768947660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  rose 3.25% to $8.59 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 2.39% to 22,954.32 and Dow Jones Industrial Average  falling 1.76% to 48,488.59.This was the stock's second consecutive day of gains.Corbus Pharmaceuticals Holdings Inc. closed 58.22% below its 52-week high of $20.56, which the company achieved on October 20th.The stock outperformed some of its competitors Tuesday, as Vanda Pharmaceuticals Inc.  rose 3.21% to $7.71, Fortress Biotech Inc.  fell 6.45% to $3.48, and Viking Therapeutics Inc.  fell 1.18% to $33.52.Trading volume  remained 235,736 below its 50-day average volume of 375,024.Data source: Dow Jones Market Data, FactSet. Data compiled January 20, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2603939961","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2603939961","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603939961?lang=en_us&edition=fundamental","pubTime":"2026-01-16 06:21","pubTimestamp":1768515660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  shed 1.09% to $8.17 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index  rising 0.25% to 23,530.02 and the Dow Jones Industrial Average  rising 0.60% to 49,442.44.Corbus Pharmaceuticals Holdings Inc. closed 60.26% below its 52-week high of $20.56, which the company achieved on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Vanda Pharmaceuticals Inc.  fell 3.25% to $7.45, Fortress Biotech Inc.  rose 6.10% to $3.48, and Viking Therapeutics Inc.  fell 7.16% to $31.88.Trading volume  remained 220,568 below its 50-day average volume of 397,003.Data source: Dow Jones Market Data, FactSet. Data compiled January 15, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2603157642","title":"Corbus Pharmaceuticals Holdings Inc. Stock Rises 4.0%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2603157642","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603157642?lang=en_us&edition=fundamental","pubTime":"2026-01-15 05:35","pubTimestamp":1768426500,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc. advanced 4.0% to $8.26 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 1.0% to 23,471.75 and Dow Jones Industrial Average falling 0.1% to 49,149.63.The stock's rise snapped a four-day losing streak.Corbus Pharmaceuticals Holdings Inc. closed 59.8% below its 52-week high of $20.56, which the company reached on October 20th.The stock demonstrated a mixed performance when compared to some of its peers, as Vanda Pharmaceuticals Inc. rose 3.5% to $7.70, Fortress Biotech Inc. fell 15.9% to $3.28, and Viking Therapeutics Inc. rose 11.89% to $34.34.Trading volume totaled 251,807, compared to the 50-day average of 449,979.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2603859529","title":"Corbus Pharmaceuticals Holdings Inc. Stock Falls 3.9%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2603859529","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603859529?lang=en_us&edition=fundamental","pubTime":"2026-01-13 05:35","pubTimestamp":1768253700,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc. shed 3.9% to $7.99 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.3% to 23,733.90 and the Dow Jones Industrial Average rising 0.2% to 49,590.20.This was the stock's third consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 61.1% below its 52-week high of $20.56, which the company achieved on October 20th.The stock underperformed when compared to some of its peers, as Vanda Pharmaceuticals Inc. rose 1.1% to $7.41, Fortress Biotech Inc. fell 2.3% to $4.20, and Viking Therapeutics Inc. fell 0.72% to $31.76.Trading volume totaled 240,027, compared to the 50-day average of 450,518.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2601845049","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2601845049","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601845049?lang=en_us&edition=fundamental","pubTime":"2026-01-07 06:20","pubTimestamp":1767738000,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  rose 2.81% to $8.05 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 0.65% to 23,547.17 and the Dow Jones Industrial Average  rising 0.99% to 49,462.08.The stock's rise snapped a two-day losing streak.Corbus Pharmaceuticals Holdings Inc. closed 60.85% short of its 52-week high of $20.56, which the company achieved on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Vanda Pharmaceuticals Inc.  rose 3.30% to $8.13, Fortress Biotech Inc.  fell 1.41% to $4.21, and Viking Therapeutics Inc.  rose 0.50% to $32.30.Trading volume  remained 313,365 below its 50-day average volume of 459,621.Data source: Dow Jones Market Data, FactSet. Data compiled January 6, 2026.This content was created by MarketWatch, which is","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2600615095","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2600615095","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600615095?lang=en_us&edition=fundamental","pubTime":"2026-01-03 06:20","pubTimestamp":1767392400,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  slid 3.32% to $7.87 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.66% to 48,382.39 and the NASDAQ Composite Index  falling 0.03% to 23,235.63.Corbus Pharmaceuticals Holdings Inc. closed 61.72% short of its 52-week high of $20.56, which the company achieved on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Vanda Pharmaceuticals Inc.  fell 6.46% to $8.25, Fortress Biotech Inc.  rose 10.11% to $4.03, and Viking Therapeutics Inc.  rose 0.68% to $35.42.Trading volume  remained 248,951 below its 50-day average volume of 471,169.Data source: Dow Jones Market Data, FactSet. Data compiled January 2, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2600146704","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2600146704","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600146704?lang=en_us&edition=fundamental","pubTime":"2026-01-01 06:22","pubTimestamp":1767219720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  rallied 1.62% to $8.14 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 0.76% to 23,241.99 and Dow Jones Industrial Average  falling 0.63% to 48,063.29.The stock's rise snapped a three-day losing streak.Corbus Pharmaceuticals Holdings Inc. closed 60.41% short of its 52-week high of $20.56, which the company reached on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Vanda Pharmaceuticals Inc.  rose 25.46% to $8.82, Fortress Biotech Inc.  rose 2.23% to $3.66, and Viking Therapeutics Inc.  fell 0.40% to $35.18.Data source: Dow Jones Market Data, FactSet. Data compiled December 31, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2595755590","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2595755590","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595755590?lang=en_us&edition=fundamental","pubTime":"2025-12-30 06:22","pubTimestamp":1767046920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  slipped 1.20% to $8.23 Monday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 0.50% to 23,474.35 and Dow Jones Industrial Average  falling 0.51% to 48,461.93.This was the stock's second consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 59.97% short of its 52-week high of $20.56, which the company reached on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc.  rose 2.27% to $7.20, Fortress Biotech Inc.  fell 4.28% to $3.58, and Viking Therapeutics Inc.  fell 1.94% to $36.46.Trading volume  remained 292,689 below its 50-day average volume of 514,668.Data source: Dow Jones Market Data, FactSet. Data compiled December 29, 2025.This content was created by MarketWatch, which i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2594215152","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2594215152","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594215152?lang=en_us&edition=fundamental","pubTime":"2025-12-27 06:22","pubTimestamp":1766787720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  slipped 1.19% to $8.33 Friday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 0.09% to 23,593.10 and Dow Jones Industrial Average  falling 0.04% to 48,710.97.Corbus Pharmaceuticals Holdings Inc. closed 59.48% below its 52-week high of $20.56, which the company achieved on October 20th.The stock underperformed when compared to some of its competitors Friday, as Vanda Pharmaceuticals Inc.  rose 1.88% to $7.04, Fortress Biotech Inc.  rose 1.91% to $3.74, and Viking Therapeutics Inc.  fell 0.46% to $37.18.Trading volume  remained 382,071 below its 50-day average volume of 521,082.Data source: Dow Jones Market Data, FactSet. Data compiled December 26, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from D","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2594407394","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2594407394","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594407394?lang=en_us&edition=fundamental","pubTime":"2025-12-25 06:23","pubTimestamp":1766614980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  advanced 2.93% to $8.43 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 0.22% to 23,613.31 and the Dow Jones Industrial Average  rising 0.60% to 48,731.16.Corbus Pharmaceuticals Holdings Inc. closed 59.00% short of its 52-week high of $20.56, which the company reached on October 20th.The stock outperformed some of its competitors Wednesday, as Vanda Pharmaceuticals Inc.  rose 1.02% to $6.91, Fortress Biotech Inc.  rose 1.94% to $3.67, and Viking Therapeutics Inc.  rose 2.58% to $37.35.Trading volume  remained 440,825 below its 50-day average volume of 525,390.Data source: Dow Jones Market Data, FactSet. Data compiled December 24, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow J","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2593555924","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2593555924","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593555924?lang=en_us&edition=fundamental","pubTime":"2025-12-23 06:23","pubTimestamp":1766442180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  rose 2.71% to $8.34 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 0.52% to 23,428.83 and the Dow Jones Industrial Average  rising 0.47% to 48,362.68.This was the stock's second consecutive day of gains.Corbus Pharmaceuticals Holdings Inc. closed 59.44% short of its 52-week high of $20.56, which the company achieved on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc.  rose 4.15% to $7.03, Fortress Biotech Inc.  rose 2.26% to $3.62, and Viking Therapeutics Inc.  rose 0.60% to $35.40.Trading volume  remained 304,423 below its 50-day average volume of 532,722.Data source: Dow Jones Market Data, FactSet. Data compiled December 22, 2025.This content was created by MarketWatch, whic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2592181920","title":"Corbus Pharmaceuticals Board Member Alan Holmer Resigns Effective December 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2592181920","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592181920?lang=en_us&edition=fundamental","pubTime":"2025-12-19 05:06","pubTimestamp":1766091973,"startTime":"0","endTime":"0","summary":"Corbus Pharmaceuticals Holdings Inc. announced that Alan Holmer has resigned from its Board of Directors, effective December 31, 2025, due to retirement. The company stated that his decision was not related to any disagreement with its operations, policies, or practices.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corbus Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 18, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL2yb5YW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP","BK4139"],"gpt_icon":0},{"id":"2592994563","title":"Corbus Pharmaceuticals Holdings Inc. Stock Slides 5.9%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2592994563","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592994563?lang=en_us&edition=fundamental","pubTime":"2025-12-18 05:34","pubTimestamp":1766007240,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc. slipped 5.9% to $8.15 on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 1.8% to 22,693.32 and Dow Jones Industrial Average falling 0.5% to 47,885.97.This was the stock's third consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 60.4% below its 52-week high of $20.56, which the company reached on October 20th.The stock underperformed when compared to some of its peers, as Vanda Pharmaceuticals Inc. rose 2.6% to $6.82, Fortress Biotech Inc. fell 2.3% to $3.43, and Viking Therapeutics Inc. fell 3.98% to $34.30.Trading volume totaled 345,815, compared to the 50-day average of 529,320.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2591306627","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2591306627","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591306627?lang=en_us&edition=fundamental","pubTime":"2025-12-16 06:22","pubTimestamp":1765837320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  slid 2.27% to $9.48 Monday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 0.59% to 23,057.41 and Dow Jones Industrial Average  falling 0.09% to 48,416.56.Corbus Pharmaceuticals Holdings Inc. closed 53.89% below its 52-week high of $20.56, which the company achieved on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc.  rose 6.42% to $6.63, Fortress Biotech Inc.  rose 13.31% to $3.32, and Viking Therapeutics Inc.  fell 2.51% to $36.15.Data source: Dow Jones Market Data, FactSet. Data compiled December 15, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2591551624","title":"Cormorant Asset Management Reports Sale of Corbus Pharmaceuticals Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2591551624","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591551624?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:18","pubTimestamp":1765833524,"startTime":"0","endTime":"0","summary":"Cormorant Asset Management, LP, a 10% owner, reported a disposal of common shares of Corbus Pharmaceuticals Holdings Inc. Other reporting beneficial owners include Cormorant Global Healthcare Master Fund, LP and Bihua Chen, among others. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corbus Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 15, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDL7vvgnK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Cormorant Asset Management Reports Sale of Corbus Pharmaceuticals Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP","BK4139"],"gpt_icon":0},{"id":"2590054194","title":"Corbus Pharmaceuticals Holdings Inc. Stock Slides 5.7%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2590054194","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590054194?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:32","pubTimestamp":1765488720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc. slipped 5.7% to $9.68 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 1.3% to 48,704.01 and the NASDAQ Composite Index falling 0.3% to 23,593.86.Corbus Pharmaceuticals Holdings Inc. closed 52.9% short of its 52-week high of $20.56, which the company reached on October 20th.The stock underperformed when compared to some of its peers, as Vanda Pharmaceuticals Inc. fell 2.2% to $6.60, Fortress Biotech Inc. remained unchanged, and Viking Therapeutics Inc. fell 0.85% to $37.21.Trading volume totaled 5.0 million, compared to the 50-day average of 422,999.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2590518435","title":"Corbus Pharmaceuticals Holdings Inc - Crb-913 Safe and Well-Tolerated Across All Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=2590518435","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590518435?lang=en_us&edition=fundamental","pubTime":"2025-12-11 20:00","pubTimestamp":1765454402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nTUA1ZSRVH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CRBP"],"gpt_icon":0},{"id":"2590518195","title":"Corbus Pharmaceuticals Reports Results From Phase 1a Study of Oral CB1 Inverse Agonist Crb-913 for the Treatment for Obesity Demonstrating Favorable Safety Profile and Emerging Evidence of Weight Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2590518195","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590518195?lang=en_us&edition=fundamental","pubTime":"2025-12-11 20:00","pubTimestamp":1765454402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nTUA1ZSRVH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CRBP"],"gpt_icon":0},{"id":"2590484518","title":"Corbus Pharmaceuticals Holdings Inc - 12-Week Dose-Finding Study Initiated, Completion Expected Summer 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2590484518","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590484518?lang=en_us&edition=fundamental","pubTime":"2025-12-11 20:00","pubTimestamp":1765454402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nTUA1ZSRVH:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CRBP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.corbuspharma.com","stockEarnings":[{"period":"1week","weight":0.0493},{"period":"1month","weight":0.0356},{"period":"3month","weight":-0.4828},{"period":"6month","weight":-0.0572},{"period":"1year","weight":-0.1909},{"period":"ytd","weight":0.0725}],"compareEarnings":[{"period":"1week","weight":-0.0035},{"period":"1month","weight":-0.0017},{"period":"3month","weight":0.0177},{"period":"6month","weight":0.0818},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.0107}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.368495},{"month":2,"riseRate":0.3,"avgChangeRate":-0.057173},{"month":3,"riseRate":0.6,"avgChangeRate":0.208224},{"month":4,"riseRate":0.5,"avgChangeRate":0.045906},{"month":5,"riseRate":0.636364,"avgChangeRate":0.079186},{"month":6,"riseRate":0.272727,"avgChangeRate":-0.065346},{"month":7,"riseRate":0.272727,"avgChangeRate":-0.050382},{"month":8,"riseRate":0.636364,"avgChangeRate":0.095672},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.086452},{"month":10,"riseRate":0.181818,"avgChangeRate":-0.124298},{"month":11,"riseRate":0.727273,"avgChangeRate":0.130055},{"month":12,"riseRate":0.272727,"avgChangeRate":-0.132264}],"exchange":"NASDAQ","name":"Corbus Pharmaceuticals","nameEN":"Corbus Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.1","shortVersion":"4.36.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Corbus Pharmaceuticals(CRBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Corbus Pharmaceuticals(CRBP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Corbus Pharmaceuticals,CRBP,Corbus Pharmaceuticals股票,Corbus Pharmaceuticals股票老虎,Corbus Pharmaceuticals股票老虎国际,Corbus Pharmaceuticals行情,Corbus Pharmaceuticals股票行情,Corbus Pharmaceuticals股价,Corbus Pharmaceuticals股市,Corbus Pharmaceuticals股票价格,Corbus Pharmaceuticals股票交易,Corbus Pharmaceuticals股票购买,Corbus Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Corbus Pharmaceuticals(CRBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Corbus Pharmaceuticals(CRBP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction